MedTrace Logo

Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study

NCT02420756 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18488

Last updated 2021-07-23

No results posted yet for this study

Summary

The Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study will establish an open-label, longitudinal cohort study to assess the impact of amyloid PET on patient outcomes. The study will be performed in accordance with the Center for Medicare \& Medicaid Services (CMS) policy of Coverage with Evidence Development (CED) in Medicare beneficiaries who meet the Appropriate Use Criteria (AUC) for amyloid PET (Johnson et al. 2013). Our hypothesis is that amyloid PET will decrease uncertainty and increase confidence in the underlying cause of cognitive impairment, that this will translate into earlier counseling and interventions in these domains, and that these interventions will lead to improved outcomes.

Conditions

Interventions

DEVICE

PET Scan

Sponsors & Collaborators

  • Alzheimer's Association

    collaborator OTHER

  • American College of Radiology Imaging Network

    collaborator NETWORK

  • American College of Radiology

    lead OTHER

Principal Investigators

  • Gil D Rabinovici, MD · University of California, San Francisco

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02420756 on ClinicalTrials.gov